139 related articles for article (PubMed ID: 16814484)
1. Altered expression of the KLF4 in colorectal cancers.
Choi BJ; Cho YG; Song JW; Kim CJ; Kim SY; Nam SW; Yoo NJ; Lee JY; Park WS
Pathol Res Pract; 2006; 202(8):585-9. PubMed ID: 16814484
[TBL] [Abstract][Full Text] [Related]
2. Clinicopathological significance of nuclear PTEN expression in colorectal adenocarcinoma.
Jang KS; Song YS; Jang SH; Min KW; Na W; Jang SM; Jun YJ; Lee KH; Choi D; Paik SS
Histopathology; 2010 Jan; 56(2):229-39. PubMed ID: 20102402
[TBL] [Abstract][Full Text] [Related]
3. Downregulation of Krüppel-like factor 9 in human colorectal cancer.
Kang L; Lü B; Xu J; Hu H; Lai M
Pathol Int; 2008 Jun; 58(6):334-8. PubMed ID: 18477211
[TBL] [Abstract][Full Text] [Related]
4. Leptin expression correlates with favorable clinicopathologic phenotype and better prognosis in colorectal adenocarcinoma.
Paik SS; Jang SM; Jang KS; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2009 Feb; 16(2):297-303. PubMed ID: 19050975
[TBL] [Abstract][Full Text] [Related]
5. Reduced expression of Apaf-1 in colorectal adenocarcinoma correlates with tumor progression and aggressive phenotype.
Paik SS; Jang KS; Song YS; Jang SH; Min KW; Han HX; Na W; Lee KH; Choi D; Jang SJ
Ann Surg Oncol; 2007 Dec; 14(12):3453-9. PubMed ID: 17882496
[TBL] [Abstract][Full Text] [Related]
6. Minichromosome maintenance protein 2 (MCM2) is a stronger discriminator of increased proliferation in mucosa adjacent to colorectal cancer than Ki-67.
Hanna-Morris A; Badvie S; Cohen P; McCullough T; Andreyev HJ; Allen-Mersh TG
J Clin Pathol; 2009 Apr; 62(4):325-30. PubMed ID: 18474544
[TBL] [Abstract][Full Text] [Related]
7. Genetic and epigenetic analysis of the KLF4 gene in gastric cancer.
Cho YG; Song JH; Kim CJ; Nam SW; Yoo NJ; Lee JY; Park WS
APMIS; 2007 Jul; 115(7):802-8. PubMed ID: 17614846
[TBL] [Abstract][Full Text] [Related]
8. Role of the mitogen-activated protein kinase and phosphoinositide 3-kinase/AKT pathways downstream molecules, phosphorylated extracellular signal-regulated kinase, and phosphorylated AKT in colorectal cancer-a tissue microarray-based approach.
Lugli A; Zlobec I; Minoo P; Baker K; Tornillo L; Terracciano L; Jass JR
Hum Pathol; 2006 Aug; 37(8):1022-31. PubMed ID: 16867865
[TBL] [Abstract][Full Text] [Related]
9. Expression of nuclear and cytoplasmic phosphorylated FADD in gastric cancers.
Yoo NJ; Lee SH; Jeong EG; Lee JW; Soung YH; Nam SW; Kim SH; Lee JY; Lee SH
Pathol Res Pract; 2007; 203(2):73-8. PubMed ID: 17207586
[TBL] [Abstract][Full Text] [Related]
10. Expression of CARD6, an NF-kappaB activator, in gastric, colorectal and oesophageal cancers.
Kim SS; Ahn CH; Kang MR; Kim YR; Kim HS; Yoo NJ; Lee SH
Pathology; 2010 Jan; 42(1):50-3. PubMed ID: 20025480
[TBL] [Abstract][Full Text] [Related]
11. The zinc finger protein OZF (ZNF146) is overexpressed in colorectal cancer.
Ferbus D; Bovin C; Validire P; Goubin G
J Pathol; 2003 Jun; 200(2):177-82. PubMed ID: 12754738
[TBL] [Abstract][Full Text] [Related]
12. Estrogen receptor beta is expressed in human colorectal adenocarcinoma.
Witte D; Chirala M; Younes A; Li Y; Younes M
Hum Pathol; 2001 Sep; 32(9):940-4. PubMed ID: 11567223
[TBL] [Abstract][Full Text] [Related]
13. Suppression of human selenium-binding protein 1 is a late event in colorectal carcinogenesis and is associated with poor survival.
Kim H; Kang HJ; You KT; Kim SH; Lee KY; Kim TI; Kim C; Song SY; Kim HJ; Lee C; Kim H
Proteomics; 2006 Jun; 6(11):3466-76. PubMed ID: 16645984
[TBL] [Abstract][Full Text] [Related]
14. Tissue microarray analysis of 560 patients with colorectal adenocarcinoma: high expression of HuR predicts poor survival.
Yoo PS; Sullivan CA; Kiang S; Gao W; Uchio EM; Chung GG; Cha CH
Ann Surg Oncol; 2009 Jan; 16(1):200-7. PubMed ID: 19009247
[TBL] [Abstract][Full Text] [Related]
15. Loss of Krüppel-like factor 4 expression contributes to Sp1 overexpression and human gastric cancer development and progression.
Kanai M; Wei D; Li Q; Jia Z; Ajani J; Le X; Yao J; Xie K
Clin Cancer Res; 2006 Nov; 12(21):6395-402. PubMed ID: 17085651
[TBL] [Abstract][Full Text] [Related]
16. Altered expression of KCNK9 in colorectal cancers.
Kim CJ; Cho YG; Jeong SW; Kim YS; Kim SY; Nam SW; Lee SH; Yoo NJ; Lee JY; Park WS
APMIS; 2004 Sep; 112(9):588-94. PubMed ID: 15601307
[TBL] [Abstract][Full Text] [Related]
17. Overexpression of serine-threonine receptor kinase-associated protein in colorectal cancers.
Kim CJ; Choi BJ; Song JH; Park YK; Cho YG; Nam SW; Yoo NJ; Lee JY; Park WS
Pathol Int; 2007 Apr; 57(4):178-82. PubMed ID: 17316412
[TBL] [Abstract][Full Text] [Related]
18. CD24 is a new oncogene, early at the multistep process of colorectal cancer carcinogenesis.
Sagiv E; Memeo L; Karin A; Kazanov D; Jacob-Hirsch J; Mansukhani M; Rechavi G; Hibshoosh H; Arber N
Gastroenterology; 2006 Aug; 131(2):630-9. PubMed ID: 16890615
[TBL] [Abstract][Full Text] [Related]
19. Loss of programmed cell death 4 expression marks adenoma-carcinoma transition, correlates inversely with phosphorylated protein kinase B, and is an independent prognostic factor in resected colorectal cancer.
Mudduluru G; Medved F; Grobholz R; Jost C; Gruber A; Leupold JH; Post S; Jansen A; Colburn NH; Allgayer H
Cancer; 2007 Oct; 110(8):1697-707. PubMed ID: 17849461
[TBL] [Abstract][Full Text] [Related]
20. Legumain expression in relation to clinicopathologic and biological variables in colorectal cancer.
Murthy RV; Arbman G; Gao J; Roodman GD; Sun XF
Clin Cancer Res; 2005 Mar; 11(6):2293-9. PubMed ID: 15788679
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
